| Correlation of circular RNA abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues A Bachmayr-Heyda, AT Reiner, K Auer, N Sukhbaatar, S Aust, ... Scientific reports 5 (1), 8057, 2015 | 744 | 2015 |
| Cyanobacterial respiration G Schmetterer The molecular biology of cyanobacteria, 409-435, 1994 | 195 | 1994 |
| Contribution of epigenetic silencing of tumor necrosis factor–related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer P Horak, D Pils, G Haller, I Pribill, M Roessler, S Tomek, R Horvat, ... Molecular cancer research 3 (6), 335-343, 2005 | 185 | 2005 |
| Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure B Meder, J Haas, F Sedaghat-Hamedani, E Kayvanpour, K Frese, A Lai, ... Circulation 136 (16), 1528-1544, 2017 | 166 | 2017 |
| Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium E Obermayr, DC Castillo-Tong, D Pils, P Speiser, I Braicu, T Van Gorp, ... Gynecologic oncology 128 (1), 15-21, 2013 | 142 | 2013 |
| Cytochrome c oxidase genes required for nitrogenase activity and diazotrophic growth in Anabaena sp. PCC 7120 A Valladares, A Herrero, D Pils, G Schmetterer, E Flores Molecular microbiology 47 (5), 1239-1249, 2003 | 133 | 2003 |
| Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer S Aust, T Knogler, D Pils, E Obermayr, A Reinthaller, L Zahn, I Radlgruber, ... PloS one 10 (10), e0140403, 2015 | 125 | 2015 |
| Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival D Pils, P Horak, A Gleiss, C Sax, G Fabjani, VJ Moebus, C Zielinski, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 125 | 2005 |
| Characterization of three bioenergetically active respiratory terminal oxidases in the cyanobacterium Synechocystis sp. strain PCC 6803 D Pils, G Schmetterer FEMS Microbiology Letters 203 (2), 217-222, 2001 | 117 | 2001 |
| In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway D Pils, A Pinter, J Reibenwein, A Alfanz, P Horak, BC Schmid, L Hefler, ... British journal of cancer 96 (3), 485-491, 2007 | 116 | 2007 |
| A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer-a study of the OVCAD consortium D Pils, D Tong, G Hager, E Obermayr, S Aust, G Heinze, M Kohl, ... Bmc Cancer 13, 1-13, 2013 | 104 | 2013 |
| Promoter hypermethylation of GSTP1, AR, and 14‐3‐3σ in serum of prostate cancer patients and its clinical relevance J Reibenwein, D Pils, P Horak, B Tomicek, G Goldner, N Worel, K Elandt, ... The Prostate 67 (4), 427-432, 2007 | 95 | 2007 |
| Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs S Tomek, P Horak, I Pribill, G Haller, M Rössler, CC Zielinski, D Pils, ... Gynecologic oncology 94 (1), 107-114, 2004 | 84 | 2004 |
| Oncogenic BARD1 isoforms expressed in gynecological cancers L Li, S Ryser, E Dizin, D Pils, M Krainer, CE Jefford, F Bertoni, R Zeillinger, ... Cancer research 67 (24), 11876-11885, 2007 | 83 | 2007 |
| Perturbation of the tumor necrosis factor–related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 … P Horak, D Pils, A Kaider, A Pinter, K Elandt, C Sax, CC Zielinski, ... Clinical cancer research 11 (24), 8585-8591, 2005 | 82 | 2005 |
| Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation S Bondong, H Kiefel, T Hielscher, AG Zeimet, R Zeillinger, D Pils, ... Annals of oncology 23 (7), 1795-1802, 2012 | 79 | 2012 |
| Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients-a study of the OVCAD consortium A Bachmayr-Heyda, S Aust, G Heinze, S Polterauer, C Grimm, EI Braicu, ... BMC cancer 13, 1-8, 2013 | 75 | 2013 |
| Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium D Pils, G Hager, D Tong, S Aust, G Heinze, M Kohl, E Schuster, A Wolf, ... Cancer science 103 (7), 1334-1341, 2012 | 72 | 2012 |
| TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo P Horak, E Tomasich, P Vaňhara, K Kratochvílová, M Anees, M Marhold, ... Scientific reports 4 (1), 3739, 2014 | 71 | 2014 |
| Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways A Kirisits, D Pils, M Krainer The international journal of biochemistry & cell biology 39 (12), 2173-2182, 2007 | 69 | 2007 |
Robert ZeillingerProfessor of Tumor BiologyVerified email at muv.ac.at
